Review



anti jagged1 notch3 blocking antibody  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    R&D Systems anti jagged1 notch3 blocking antibody
    Anti Jagged1 Notch3 Blocking Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 36 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+notch3+blocking+antibodies/Human+Jagged+1+Antibody/pmc05392366-155-13-18
    Average 94 stars, based on 36 article reviews
    anti jagged1 notch3 blocking antibody - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    Blocking Assay:

    Article Title: Human blood vessel organoids as a model of diabetic vasculopathy
    Article Snippet: DAPT (Selleckchem S2215) was dissolved in ethanol and injected with 90% cornoil for 5 consecutive days at 5mg/kg with 2 days of no treatment per week. .. Anti-Notch3 blocking antibodies (R&D AF1559) were injected 3 time/week at 1mg/kg. ..

    Injection:

    Article Title: Human blood vessel organoids as a model of diabetic vasculopathy
    Article Snippet: DAPT (Selleckchem S2215) was dissolved in ethanol and injected with 90% cornoil for 5 consecutive days at 5mg/kg with 2 days of no treatment per week. .. Anti-Notch3 blocking antibodies (R&D AF1559) were injected 3 time/week at 1mg/kg. ..



    Similar Products

    anti notch3 blocking antibodies  (R&D Systems Hematology)
    92
    R&D Systems Hematology anti notch3 blocking antibodies
    a, Representative images of Col IV in diabetic blood vessel organoids (NC8), treated with antibodies against Jagged-1, Notch1, <t>Notch3,</t> or recombinant Dll1 and Dll4. The thickness of the Col IV+ coat of vessels was measured in optical cross-sections. Non-diabetic n=132, Vehicle n=139, α-Jagged1 n=141, Dll1 n=132, Dll4 n=153, α-Notch1 n=156, <t>α-Notch3</t> n=156 lumina were analysed from 3 independent biological replicates with equal sample size. Mean ± SD. *** p<0.0001 (One-way ANOVA). b, Dermal blood vessels of T2D patients (diabetic) and healthy controls (non-diabetic) were stained for Notch3 and SMA. c, Hes5 and SMA were co-stained in dermal sections of T2D patients (diabetic) and non-diabetic controls. Note the strong Hes5 signal in pericytes (SMA) of diabetic patients. d,e, Quantification of Notch3 and Hes5 expression data from c and d. Mean ± S.E.M of n = (non-diabetic =4, diabetic=4) independent patients. * p=0.043 two-tailed student t-test. Scale bars a=50μm, b,c=20μm.
    Anti Notch3 Blocking Antibodies, supplied by R&D Systems Hematology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+notch3+blocking+antibodies/Human+Notch-3+Antibody/pmc07116578-220-0-3
    Average 92 stars, based on 1 article reviews
    anti notch3 blocking antibodies - by Bioz Stars, 2026-09
    92/100 stars
    		  Buy from Supplier
    anti jagged1 notch3 blocking antibody  (R&D Systems)
    94
    R&D Systems anti jagged1 notch3 blocking antibody
    a, Representative images of Col IV in diabetic blood vessel organoids (NC8), treated with antibodies against Jagged-1, Notch1, <t>Notch3,</t> or recombinant Dll1 and Dll4. The thickness of the Col IV+ coat of vessels was measured in optical cross-sections. Non-diabetic n=132, Vehicle n=139, α-Jagged1 n=141, Dll1 n=132, Dll4 n=153, α-Notch1 n=156, <t>α-Notch3</t> n=156 lumina were analysed from 3 independent biological replicates with equal sample size. Mean ± SD. *** p<0.0001 (One-way ANOVA). b, Dermal blood vessels of T2D patients (diabetic) and healthy controls (non-diabetic) were stained for Notch3 and SMA. c, Hes5 and SMA were co-stained in dermal sections of T2D patients (diabetic) and non-diabetic controls. Note the strong Hes5 signal in pericytes (SMA) of diabetic patients. d,e, Quantification of Notch3 and Hes5 expression data from c and d. Mean ± S.E.M of n = (non-diabetic =4, diabetic=4) independent patients. * p=0.043 two-tailed student t-test. Scale bars a=50μm, b,c=20μm.
    Anti Jagged1 Notch3 Blocking Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+notch3+blocking+antibodies/Human+Jagged+1+Antibody/pmc05392366-155-13-18
    Average 94 stars, based on 1 article reviews
    anti jagged1 notch3 blocking antibody - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    a, Representative images of Col IV in diabetic blood vessel organoids (NC8), treated with antibodies against Jagged-1, Notch1, Notch3, or recombinant Dll1 and Dll4. The thickness of the Col IV+ coat of vessels was measured in optical cross-sections. Non-diabetic n=132, Vehicle n=139, α-Jagged1 n=141, Dll1 n=132, Dll4 n=153, α-Notch1 n=156, α-Notch3 n=156 lumina were analysed from 3 independent biological replicates with equal sample size. Mean ± SD. *** p<0.0001 (One-way ANOVA). b, Dermal blood vessels of T2D patients (diabetic) and healthy controls (non-diabetic) were stained for Notch3 and SMA. c, Hes5 and SMA were co-stained in dermal sections of T2D patients (diabetic) and non-diabetic controls. Note the strong Hes5 signal in pericytes (SMA) of diabetic patients. d,e, Quantification of Notch3 and Hes5 expression data from c and d. Mean ± S.E.M of n = (non-diabetic =4, diabetic=4) independent patients. * p=0.043 two-tailed student t-test. Scale bars a=50μm, b,c=20μm.

    Journal: Nature

    Article Title: Human blood vessel organoids as a model of diabetic vasculopathy

    doi: 10.1038/s41586-018-0858-8

    Figure Lengend Snippet: a, Representative images of Col IV in diabetic blood vessel organoids (NC8), treated with antibodies against Jagged-1, Notch1, Notch3, or recombinant Dll1 and Dll4. The thickness of the Col IV+ coat of vessels was measured in optical cross-sections. Non-diabetic n=132, Vehicle n=139, α-Jagged1 n=141, Dll1 n=132, Dll4 n=153, α-Notch1 n=156, α-Notch3 n=156 lumina were analysed from 3 independent biological replicates with equal sample size. Mean ± SD. *** p<0.0001 (One-way ANOVA). b, Dermal blood vessels of T2D patients (diabetic) and healthy controls (non-diabetic) were stained for Notch3 and SMA. c, Hes5 and SMA were co-stained in dermal sections of T2D patients (diabetic) and non-diabetic controls. Note the strong Hes5 signal in pericytes (SMA) of diabetic patients. d,e, Quantification of Notch3 and Hes5 expression data from c and d. Mean ± S.E.M of n = (non-diabetic =4, diabetic=4) independent patients. * p=0.043 two-tailed student t-test. Scale bars a=50μm, b,c=20μm.

    Article Snippet: Anti-Notch3 blocking antibodies (R&D AF1559) were injected 3 time/week at 1mg/kg.

    Techniques: Recombinant, Staining, Expressing, Two Tailed Test